Related Experiment Videos

Renal oncocytoma: clinical and biological correlates

M R Licht1, A C Novick, R R Tubbs

  • 1Department of Urology, Cleveland Clinic Foundation, Ohio 44195.

The Journal of Urology
|November 1, 1993
PubMed

Insights

Renal oncocytomas often coexist with renal cell carcinoma. Loss of HLA class I antigen expression in oncocytomas may help distinguish them from renal cell carcinoma, aiding diagnosis.

Area of Science:

  • Urology
  • Oncology
  • Immunology

Background:

  • Renal oncocytoma is a benign kidney tumor.
  • Renal cell carcinoma is a malignant kidney tumor.
  • Coexistence of both in the same or contralateral kidney is observed.

Purpose of the Study:

  • To investigate the coexistence of renal oncocytoma and renal cell carcinoma.
  • To evaluate the expression of HLA class I antigens in renal oncocytomas.
  • To determine if HLA class I expression can differentiate these tumors.

Main Methods:

  • Quantitative DNA analysis (flow cytometry/image cytometry) for ploidy.
  • Immunohistology for HLA class I antigen expression (monoclonal antibody).
  • Analysis of patient data including tumor coexistence and outcomes.

Main Results:

  • All renal oncocytomas analyzed were diploid.
  • 10 out of 11 renal oncocytomas showed no or weak HLA class I antigen expression.
  • In contrast, renal cell carcinomas strongly expressed HLA class I antigens.

Conclusions:

  • A high incidence of renal oncocytoma and renal cell carcinoma coexistence was noted.
  • Loss of HLA class I antigen expression is characteristic of renal oncocytomas.
  • HLA class I antigen expression analysis may aid in differentiating renal oncocytoma from renal cell carcinoma.

Related Concept Videos